| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.34 | 2e-06 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.33 | 5e-06 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0006 |